Header Logo

Jerry Jaboin

Concepts (378)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiation Oncology
15
2022
19
4.910
Why?
Brain Neoplasms
14
2022
301
3.970
Why?
Radiosurgery
9
2021
84
3.210
Why?
Meningeal Neoplasms
6
2021
73
3.020
Why?
Meningioma
6
2018
79
2.430
Why?
Publications
4
2018
24
2.280
Why?
Internship and Residency
7
2021
239
2.250
Why?
Radiotherapy
6
2021
41
1.950
Why?
Career Choice
5
2020
53
1.850
Why?
Neurosurgical Procedures
5
2021
217
1.820
Why?
Medical Oncology
4
2025
93
1.590
Why?
Humans
80
2025
27968
1.440
Why?
Radiation Oncologists
7
2020
7
1.350
Why?
Practice Patterns, Physicians'
7
2020
163
1.280
Why?
Lung Neoplasms
8
2020
353
1.220
Why?
United States
18
2025
2139
1.120
Why?
African Americans
3
2018
352
1.090
Why?
Databases, Factual
4
2021
253
1.080
Why?
Neuroma, Acoustic
2
2017
23
1.080
Why?
Glioblastoma
4
2020
105
0.980
Why?
Neoplasm Recurrence, Local
5
2021
330
0.980
Why?
Male
33
2025
13424
0.950
Why?
Combined Modality Therapy
10
2022
297
0.920
Why?
Private Practice
4
2021
8
0.910
Why?
Bibliometrics
3
2018
19
0.870
Why?
Muscle Proteins
2
2015
56
0.870
Why?
Aged
19
2021
5383
0.860
Why?
Female
32
2025
15074
0.840
Why?
Radiotherapy, Intensity-Modulated
3
2021
37
0.810
Why?
Nerve Tissue Proteins
2
2015
152
0.810
Why?
Melanoma
2
2021
140
0.790
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2021
407
0.790
Why?
Authorship
2
2018
14
0.750
Why?
Peer Review, Research
2
2018
9
0.730
Why?
Spinal Neoplasms
2
2020
39
0.720
Why?
Astrocytoma
1
2021
35
0.720
Why?
Autophagy
4
2009
73
0.710
Why?
Prostatic Neoplasms
4
2017
277
0.710
Why?
Education, Medical, Graduate
2
2018
108
0.710
Why?
Glioma
1
2022
117
0.700
Why?
Lymphoma
1
2020
25
0.700
Why?
Whole-Body Irradiation
1
2020
40
0.700
Why?
Middle Aged
21
2021
7111
0.690
Why?
Carcinoma, Non-Small-Cell Lung
2
2019
105
0.680
Why?
Emergency Service, Hospital
1
2021
120
0.680
Why?
Socioeconomic Factors
1
2021
248
0.680
Why?
Students, Medical
2
2018
96
0.670
Why?
Healthcare Disparities
1
2021
90
0.670
Why?
Germinoma
1
2019
4
0.650
Why?
Central Nervous System Neoplasms
1
2019
13
0.640
Why?
Neoplasms
5
2021
803
0.640
Why?
Polymorphism, Single Nucleotide
3
2010
546
0.620
Why?
Health Policy
1
2019
61
0.620
Why?
Anterior Temporal Lobectomy
1
2018
1
0.610
Why?
Epilepsy, Temporal Lobe
1
2018
4
0.610
Why?
Wireless Technology
1
2018
2
0.610
Why?
Adenocarcinoma
3
2010
297
0.610
Why?
Magnetic Field Therapy
1
2018
3
0.600
Why?
Financing, Personal
1
2018
4
0.600
Why?
Apoptosis
7
2015
772
0.600
Why?
Cell Phone
1
2018
20
0.600
Why?
Radiotherapy, Adjuvant
2
2018
60
0.590
Why?
Patient Safety
1
2018
38
0.590
Why?
Neurosurgery
4
2021
75
0.580
Why?
Receptor, trkB
4
2012
6
0.570
Why?
Lymphocytes
1
2018
90
0.570
Why?
Ventral Thalamic Nuclei
1
2017
1
0.570
Why?
Essential Tremor
1
2017
2
0.570
Why?
Spinal Cord Compression
1
2017
20
0.560
Why?
Deep Brain Stimulation
1
2017
7
0.560
Why?
Retrospective Studies
12
2022
2541
0.560
Why?
Ambulatory Care
1
2017
60
0.550
Why?
Insurance Coverage
1
2017
31
0.540
Why?
Efficiency
5
2021
17
0.530
Why?
Medulloblastoma
1
2016
18
0.530
Why?
Prognosis
7
2021
802
0.530
Why?
Palliative Care
1
2017
82
0.520
Why?
Follow-Up Studies
5
2021
1011
0.500
Why?
Neuroblastoma
4
2005
56
0.500
Why?
Adult
12
2021
7703
0.490
Why?
Stroke
1
2018
249
0.470
Why?
Brain-Derived Neurotrophic Factor
3
2005
22
0.470
Why?
Tumor Suppressor Protein p53
1
2015
103
0.460
Why?
Small Cell Lung Carcinoma
3
2020
14
0.460
Why?
Magnetic Resonance Imaging
5
2020
817
0.440
Why?
Child
6
2021
2225
0.400
Why?
Neovascularization, Pathologic
2
2013
149
0.400
Why?
Proto-Oncogene Proteins c-myc
1
2012
44
0.390
Why?
Treatment Outcome
6
2020
2367
0.390
Why?
Cell Line, Tumor
9
2018
1314
0.380
Why?
Breast Neoplasms
3
2021
458
0.380
Why?
Kaplan-Meier Estimate
3
2017
194
0.360
Why?
Gene Expression Regulation, Neoplastic
2
2012
461
0.360
Why?
Protein Kinases
3
2012
148
0.350
Why?
Enzyme Inhibitors
4
2013
249
0.340
Why?
Central Nervous System Diseases
2
2021
13
0.340
Why?
Matrix Metalloproteinase 7
1
2010
13
0.340
Why?
Neoplastic Cells, Circulating
2
2021
25
0.330
Why?
Ferrosoferric Oxide
2
2020
5
0.330
Why?
Surveys and Questionnaires
8
2025
967
0.330
Why?
Proto-Oncogene Proteins c-mdm2
1
2009
9
0.320
Why?
Survival Rate
4
2021
428
0.310
Why?
Radiation
1
2009
3
0.310
Why?
Molecular Biology
1
2009
17
0.310
Why?
Chemoradiotherapy
2
2019
44
0.300
Why?
Seminoma
2
2018
2
0.300
Why?
Spinal Cord Neoplasms
2
2020
35
0.300
Why?
Testicular Neoplasms
2
2018
16
0.290
Why?
Radiotherapy Dosage
4
2023
104
0.290
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2018
41
0.290
Why?
Watchful Waiting
2
2018
18
0.290
Why?
Sirolimus
2
2008
76
0.290
Why?
Signal Transduction
6
2013
1433
0.280
Why?
Child, Preschool
3
2021
1133
0.280
Why?
Drug Delivery Systems
1
2009
225
0.260
Why?
Radiotherapy Planning, Computer-Assisted
2
2020
65
0.260
Why?
Proportional Hazards Models
3
2017
225
0.260
Why?
Phosphatidylinositol 3-Kinases
3
2005
135
0.260
Why?
Tumor Microenvironment
2
2025
176
0.240
Why?
Immunoblotting
3
2015
124
0.240
Why?
Cisplatin
2
2003
179
0.240
Why?
Carboplatin
3
2019
111
0.230
Why?
Triple Negative Breast Neoplasms
1
2025
36
0.230
Why?
Disease-Free Survival
2
2016
237
0.230
Why?
Hybrid Cells
2
2021
8
0.220
Why?
Cell Movement
3
2015
365
0.220
Why?
Neoplasm Staging
5
2018
478
0.210
Why?
Animals
12
2025
10370
0.200
Why?
Histone Deacetylase Inhibitors
1
2002
26
0.200
Why?
Benzamides
1
2002
34
0.200
Why?
Radiology
1
2022
20
0.200
Why?
Cell Proliferation
3
2015
802
0.200
Why?
Radiation-Sensitizing Agents
3
2013
32
0.190
Why?
Carcinoma, Squamous Cell
2
2019
163
0.190
Why?
Pyridines
1
2002
106
0.190
Why?
Carcinoma, Renal Cell
1
2022
77
0.190
Why?
Tumor Burden
2
2019
110
0.180
Why?
Kidney Neoplasms
1
2022
101
0.180
Why?
Antineoplastic Agents
3
2009
679
0.180
Why?
Cost-Benefit Analysis
1
2021
112
0.180
Why?
Peer Review
1
2020
14
0.180
Why?
Population Surveillance
2
2018
86
0.170
Why?
Societies, Medical
1
2021
92
0.170
Why?
Prevalence
2
2020
496
0.170
Why?
Image Processing, Computer-Assisted
2
2013
251
0.170
Why?
Radiotherapy, Conformal
1
2020
15
0.170
Why?
Ependymoma
1
2020
11
0.170
Why?
Cell Cycle
3
2012
161
0.170
Why?
American Recovery and Reinvestment Act
1
2019
3
0.160
Why?
Carcinoma, Large Cell
1
2019
6
0.160
Why?
Financing, Government
1
2019
7
0.160
Why?
Second-Look Surgery
1
2019
4
0.160
Why?
Radiation Injuries
2
2018
52
0.160
Why?
Arteriovenous Fistula
1
2019
16
0.160
Why?
Melphalan
1
2019
7
0.160
Why?
Lymph Nodes
1
2020
103
0.160
Why?
Intracranial Arteriovenous Malformations
1
2019
16
0.160
Why?
Salvage Therapy
1
2019
34
0.160
Why?
Gadolinium
1
2019
6
0.160
Why?
Image Interpretation, Computer-Assisted
1
2020
107
0.160
Why?
Mice
7
2021
4621
0.160
Why?
Cell Cycle Checkpoints
1
2019
30
0.160
Why?
Brain
3
2018
739
0.160
Why?
Adolescent
3
2021
3104
0.160
Why?
Photons
1
2018
27
0.150
Why?
Cavernous Sinus
1
2018
5
0.150
Why?
Brain Diseases
1
2018
35
0.150
Why?
Peptides
2
2013
287
0.150
Why?
Radio Waves
1
2018
21
0.150
Why?
Electromagnetic Fields
1
2018
14
0.150
Why?
Drug Screening Assays, Antitumor
2
2013
103
0.150
Why?
Clinical Trials, Phase III as Topic
1
2018
20
0.150
Why?
Proton Therapy
1
2018
29
0.150
Why?
Antineoplastic Agents, Immunological
1
2019
42
0.150
Why?
Lymphoma, Non-Hodgkin
1
2018
26
0.150
Why?
Hobbies
1
2018
1
0.150
Why?
Pacemaker, Artificial
1
2018
55
0.150
Why?
Carcinoma, Small Cell
1
2018
14
0.150
Why?
Cranial Irradiation
1
2018
12
0.150
Why?
Health Surveys
1
2018
82
0.150
Why?
Organ Specificity
1
2018
82
0.150
Why?
Academic Medical Centers
1
2018
75
0.150
Why?
Tumor Cells, Cultured
3
2003
315
0.150
Why?
Electric Stimulation Therapy
1
2018
56
0.150
Why?
Infertility, Male
1
2018
23
0.140
Why?
Postoperative Complications
2
2021
611
0.140
Why?
Palliative Medicine
1
2017
1
0.140
Why?
Particle Accelerators
1
2017
5
0.140
Why?
Oregon
1
2017
8
0.140
Why?
Infant
1
2021
987
0.140
Why?
Fertility
1
2018
58
0.140
Why?
Neoplasm Invasiveness
2
2021
188
0.140
Why?
Costs and Cost Analysis
1
2017
40
0.140
Why?
Bias
1
2017
42
0.140
Why?
Time-to-Treatment
1
2017
27
0.140
Why?
Young Adult
3
2019
2714
0.140
Why?
Propensity Score
1
2017
54
0.140
Why?
Recombinant Proteins
2
2012
412
0.140
Why?
Postoperative Period
1
2017
67
0.140
Why?
Immunotherapy
1
2019
159
0.140
Why?
Ambulatory Care Facilities
1
2017
54
0.140
Why?
Dose-Response Relationship, Drug
3
2003
604
0.140
Why?
Hemangioblastoma
1
2017
13
0.130
Why?
Odds Ratio
1
2017
236
0.130
Why?
Carcinoma, Pancreatic Ductal
1
2018
138
0.130
Why?
Reactive Oxygen Species
1
2018
284
0.130
Why?
DNA Fragmentation
2
2015
17
0.130
Why?
Prostatectomy
3
2017
83
0.130
Why?
DNA, Neoplasm
2
2009
34
0.130
Why?
Postoperative Care
1
2016
68
0.130
Why?
Comorbidity
1
2017
257
0.130
Why?
Protein Array Analysis
2
2013
18
0.130
Why?
Sex Factors
1
2018
465
0.130
Why?
Logistic Models
1
2017
407
0.130
Why?
Head and Neck Neoplasms
2
2009
87
0.130
Why?
Aged, 80 and over
3
2021
2015
0.120
Why?
Survival Analysis
2
2014
287
0.120
Why?
Xenograft Model Antitumor Assays
4
2018
268
0.120
Why?
Cells, Cultured
3
2021
984
0.120
Why?
Heptanoic Acids
1
2015
1
0.120
Why?
Lanosterol
1
2015
1
0.120
Why?
Catechols
1
2015
2
0.120
Why?
Fatty Alcohols
1
2015
4
0.120
Why?
Limonins
1
2015
3
0.120
Why?
Flavones
1
2015
3
0.120
Why?
Fluorescent Antibody Technique
1
2015
112
0.120
Why?
Triterpenes
1
2015
9
0.120
Why?
Immunoprecipitation
1
2015
68
0.120
Why?
Sesquiterpenes
1
2015
22
0.120
Why?
Models, Genetic
2
2012
125
0.120
Why?
Gene Knockdown Techniques
1
2015
134
0.120
Why?
Prospective Studies
1
2018
1244
0.120
Why?
Flow Cytometry
1
2015
287
0.110
Why?
Transfection
3
2005
317
0.110
Why?
Oxidative Stress
1
2018
667
0.110
Why?
Phospholipases A2, Cytosolic
1
2013
1
0.110
Why?
Benzoates
1
2013
30
0.110
Why?
Receptors, Peptide
1
2013
20
0.100
Why?
Protein Interaction Mapping
1
2013
34
0.100
Why?
Peptide Library
1
2013
26
0.100
Why?
Sulfonamides
1
2013
73
0.100
Why?
Lentivirus
1
2012
16
0.100
Why?
Enzyme Activation
2
2003
267
0.100
Why?
Receptor, trkA
1
2012
10
0.100
Why?
Pancreatic Neoplasms
1
2018
540
0.100
Why?
Radiation Tolerance
1
2012
28
0.100
Why?
HEK293 Cells
1
2012
186
0.100
Why?
Human Umbilical Vein Endothelial Cells
1
2012
64
0.090
Why?
Expert Testimony
1
2011
7
0.090
Why?
Genotype
2
2010
456
0.090
Why?
Unnecessary Procedures
1
2011
7
0.090
Why?
Mastectomy
1
2011
21
0.090
Why?
Randomized Controlled Trials as Topic
3
2018
381
0.090
Why?
TOR Serine-Threonine Kinases
2
2008
82
0.090
Why?
RNA, Messenger
1
2012
657
0.080
Why?
Phenotype
1
2012
680
0.080
Why?
Cell Death
2
2007
118
0.080
Why?
ErbB Receptors
1
2010
100
0.080
Why?
Tomography, X-Ray Computed
3
2022
473
0.080
Why?
Hypothyroidism
1
2009
11
0.080
Why?
Thyroid Gland
1
2009
32
0.080
Why?
Analysis of Variance
1
2010
391
0.080
Why?
Cell Survival
3
2018
408
0.080
Why?
Phagosomes
1
2009
6
0.080
Why?
Necrosis
1
2009
83
0.080
Why?
Capsid
1
2009
12
0.080
Why?
In Situ Nick-End Labeling
1
2009
42
0.080
Why?
Contrast Media
2
2020
95
0.080
Why?
Proto-Oncogene Proteins c-bcl-2
1
2009
68
0.080
Why?
Bacteriophage T7
1
2009
7
0.080
Why?
Adenoviridae
1
2009
67
0.080
Why?
Cloning, Molecular
1
2009
205
0.080
Why?
Polymerase Chain Reaction
1
2009
268
0.080
Why?
Caspase Inhibitors
1
2008
8
0.070
Why?
Spectroscopy, Near-Infrared
1
2009
74
0.070
Why?
Microscopy, Fluorescence
1
2009
163
0.070
Why?
Paclitaxel
2
2009
190
0.070
Why?
Chemotherapy, Adjuvant
2
2018
113
0.070
Why?
Liposomes
1
2009
145
0.070
Why?
Immunohistochemistry
1
2009
461
0.070
Why?
Amino Acid Sequence
1
2009
687
0.070
Why?
Up-Regulation
1
2008
246
0.070
Why?
Chromones
2
2005
11
0.070
Why?
Morpholines
2
2005
28
0.070
Why?
Molecular Sequence Data
1
2009
1048
0.070
Why?
Biomarkers, Tumor
2
2021
404
0.070
Why?
Practice Guidelines as Topic
2
2018
242
0.070
Why?
Macrophages
2
2020
292
0.070
Why?
Mice, Nude
2
2008
330
0.060
Why?
Mice, SCID
2
2002
60
0.060
Why?
Canada
1
2025
60
0.060
Why?
Amifostine
1
2004
5
0.060
Why?
Drug Resistance, Neoplasm
2
2005
166
0.060
Why?
Mucous Membrane
1
2004
28
0.060
Why?
Quality of Life
2
2018
484
0.060
Why?
Proto-Oncogene Proteins
1
2005
140
0.060
Why?
Algorithms
2
2020
430
0.050
Why?
Precipitin Tests
1
2003
47
0.050
Why?
Pilot Projects
1
2025
430
0.050
Why?
Vinblastine
1
2002
6
0.050
Why?
Tetracycline
1
2002
4
0.050
Why?
Etoposide
1
2002
19
0.050
Why?
Acetylation
1
2002
36
0.050
Why?
Incidental Findings
1
2022
13
0.050
Why?
Doxorubicin
1
2002
77
0.050
Why?
Histones
1
2002
92
0.050
Why?
Hospitals, Community
1
2021
8
0.050
Why?
Age Factors
2
2018
733
0.050
Why?
Adrenal Gland Neoplasms
1
2002
15
0.050
Why?
Transplantation, Heterologous
1
2002
60
0.050
Why?
Central Nervous System
1
2021
37
0.050
Why?
PubMed
1
2021
8
0.040
Why?
Promoter Regions, Genetic
1
2002
343
0.040
Why?
Time Factors
2
2018
1590
0.040
Why?
Proof of Concept Study
1
2020
12
0.040
Why?
Neuroimaging
1
2020
87
0.040
Why?
Artifacts
1
2020
50
0.040
Why?
Risk Assessment
1
2021
610
0.040
Why?
Embolization, Therapeutic
1
2019
46
0.040
Why?
Rats
1
2002
1570
0.040
Why?
Magnetite Nanoparticles
1
2019
16
0.040
Why?
Incidence
1
2020
562
0.040
Why?
Preliminary Data
1
2018
4
0.040
Why?
Endovascular Procedures
1
2019
69
0.040
Why?
Cell Fusion
1
2018
7
0.040
Why?
Karyotyping
1
2018
25
0.040
Why?
Transportation of Patients
1
2018
29
0.040
Why?
Protons
1
2018
54
0.040
Why?
Green Fluorescent Proteins
1
2018
101
0.040
Why?
Memantine
1
2018
2
0.040
Why?
Cell Line
2
2012
695
0.040
Why?
Orchiectomy
1
2018
12
0.040
Why?
Scandinavian and Nordic Countries
1
2017
2
0.040
Why?
Patient Satisfaction
1
2018
96
0.040
Why?
Cryopreservation
1
2018
13
0.040
Why?
Neuroprotective Agents
1
2018
52
0.040
Why?
Registries
1
2020
387
0.040
Why?
Phosphorylation
2
2012
574
0.040
Why?
Risk
1
2017
136
0.040
Why?
Disease Management
1
2018
88
0.030
Why?
Delivery of Health Care
1
2018
118
0.030
Why?
Length of Stay
1
2018
228
0.030
Why?
Mice, Transgenic
1
2018
507
0.030
Why?
Epithelial Cells
1
2018
247
0.030
Why?
Disease Progression
1
2018
472
0.030
Why?
Cognition Disorders
1
2018
184
0.030
Why?
Health Promotion
1
2017
176
0.030
Why?
Disease Models, Animal
2
2013
1454
0.030
Why?
Health Knowledge, Attitudes, Practice
1
2018
293
0.030
Why?
Glycogen Synthase Kinase 3 beta
1
2015
41
0.030
Why?
Glycogen Synthase Kinase 3
1
2015
31
0.030
Why?
Wnt Signaling Pathway
1
2015
56
0.030
Why?
Radiation, Ionizing
1
2013
25
0.030
Why?
Mice, Inbred C57BL
1
2018
1561
0.030
Why?
Drug Discovery
1
2013
34
0.030
Why?
Xanthones
1
2012
6
0.020
Why?
Radiation Dosage
1
2012
53
0.020
Why?
DNA Repair
1
2012
82
0.020
Why?
Automation
1
2011
19
0.020
Why?
Community Health Services
1
2011
32
0.020
Why?
Endothelial Cells
1
2013
350
0.020
Why?
Mammography
1
2011
79
0.020
Why?
Bridged-Ring Compounds
1
2009
18
0.020
Why?
Taxoids
1
2009
37
0.020
Why?
Haplotypes
1
2010
283
0.020
Why?
Radiography
1
2009
202
0.020
Why?
Everolimus
1
2008
16
0.020
Why?
Caspase 3
1
2008
57
0.020
Why?
Protein Kinase Inhibitors
1
2008
156
0.020
Why?
Models, Biological
1
2009
466
0.020
Why?
Drug Administration Schedule
1
2004
223
0.010
Why?
Proto-Oncogene Proteins c-akt
1
2005
155
0.010
Why?
Risk Factors
1
2009
2078
0.010
Why?
Genes, myc
1
2002
9
0.010
Why?
Chromosomes, Human, Pair 17
1
2002
15
0.010
Why?
Sequence Deletion
1
2002
66
0.010
Why?
Cell Division
1
2002
154
0.010
Why?
Neoplasm Metastasis
1
2002
160
0.010
Why?
Jaboin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (378)
Explore
_
Co-Authors (3)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_